The Impact of Deep Brain Stimulation on the Cognitive Ability of Patients with Parkinson Disease
Abstract
Deep Brain Stimulation, especially STN-DBS, is one of the most prevalent treatments for the Parkinson’s Disease. Previous researches already showed its positive effects on the general conditions of the patients but lack evaluation of its influence on the cognitive ability of the patients. A comparison in the effect of DBS and surgical lesioning procedures can determine DBS’s influence on the quality of life and confirm whether it is the most optimal treatment. This proposal reviewed previous researches about the influence of STN-DBS and proposed a study on its influence of patients’ cognitive ability.
References
[2] Cappon D, Beigi M, Kefalopoulou Z, et al. Globus pallidal deep brain stimulation for tourette syndrome: Effects on cognitive function. Parkinsonism & Related Disorders 2019; 69: 14–18.
[3] Furukawa S, Hirano S, Yamamoto T, et al. Decline in drawing ability and cerebral perfusion in Parkinson’s disease patients after subthalamic nucleus deep brain stimulation surgery. Parkinsonism & Related Disorders 2019; 70: 60–66.
[4] Groiss SJ, Wojtecki L, Südmeyer M, et al. Deep brain stimulation in Parkinson’s disease. Therapeutic Advances in Neurological Disorders 2009; 2(6): 20–28.
[5] Haberler C, Alesch F, Mazal PR, et al. No tissue damage by chronic deep brain stimulation in Parkinson’s disease. Annals of Neurology 2000; 48(3): 372–376.
[6] Kuncel AM, Grill WM. Selection of stimulus parameters for deep brain stimulation. Clinical Neurophysiology 2004; 115(11): 2431–2441.
[7] Pilitsis JG, Chu Y, Kordower J, et al. Postmortem study of deep brain stimulation of the anterior thalamus: Case report. Neurosurgery 2008; 62(2): E530–E532.
[8] The Lewin Group, Inc. Economic burden and future impact of Parkinson’s disease. 2019. Available from: https://www.parkinson.org/sites/default/files/2019%20Parkinson%27s%20Economic%20Burden%20Study%20-%20FINAL.pdf.
Copyright (c) 2020 Kuo Liu
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear
Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.